213 related articles for article (PubMed ID: 24705403)
1. Akt-dependent phosphorylation of hepatic FoxO1 is compartmentalized on a WD40/ProF scaffold and is selectively inhibited by aPKC in early phases of diet-induced obesity.
Sajan MP; Acevedo-Duncan ME; Standaert ML; Ivey RA; Lee M; Farese RV
Diabetes; 2014 Aug; 63(8):2690-701. PubMed ID: 24705403
[TBL] [Abstract][Full Text] [Related]
2. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
Sajan MP; Ivey RA; Lee MC; Farese RV
J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
4. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
Sajan MP; Ivey RA; Farese RV
Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
[TBL] [Abstract][Full Text] [Related]
5. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
[TBL] [Abstract][Full Text] [Related]
6. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
[TBL] [Abstract][Full Text] [Related]
7. Elovl5 regulates the mTORC2-Akt-FOXO1 pathway by controlling hepatic cis-vaccenic acid synthesis in diet-induced obese mice.
Tripathy S; Jump DB
J Lipid Res; 2013 Jan; 54(1):71-84. PubMed ID: 23099444
[TBL] [Abstract][Full Text] [Related]
8. Akt- and Foxo1-interacting WD-repeat-FYVE protein promotes adipogenesis.
Fritzius T; Moelling K
EMBO J; 2008 May; 27(9):1399-410. PubMed ID: 18388859
[TBL] [Abstract][Full Text] [Related]
9. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.
Sajan M; Hansen B; Ivey R; Sajan J; Ari C; Song S; Braun U; Leitges M; Farese-Higgs M; Farese RV
Diabetes; 2016 Jul; 65(7):1892-903. PubMed ID: 26895791
[TBL] [Abstract][Full Text] [Related]
10. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
[TBL] [Abstract][Full Text] [Related]
11. Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition.
Singh BK; Sinha RA; Zhou J; Tripathi M; Ohba K; Wang ME; Astapova I; Ghosh S; Hollenberg AN; Gauthier K; Yen PM
J Biol Chem; 2016 Jan; 291(1):198-214. PubMed ID: 26453307
[TBL] [Abstract][Full Text] [Related]
12. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Sajan MP; Nimal S; Mastorides S; Acevedo-Duncan M; Kahn CR; Fields AP; Braun U; Leitges M; Farese RV
Metabolism; 2012 Apr; 61(4):459-69. PubMed ID: 22225955
[TBL] [Abstract][Full Text] [Related]
13. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1.
Lu M; Wan M; Leavens KF; Chu Q; Monks BR; Fernandez S; Ahima RS; Ueki K; Kahn CR; Birnbaum MJ
Nat Med; 2012 Feb; 18(3):388-95. PubMed ID: 22344295
[TBL] [Abstract][Full Text] [Related]
14. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.
Sajan MP; Standaert ML; Nimal S; Varanasi U; Pastoor T; Mastorides S; Braun U; Leitges M; Farese RV
J Lipid Res; 2009 Jun; 50(6):1133-45. PubMed ID: 19202134
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glucose metabolism via hepatic forkhead transcription factor 1 (FoxO1) by Morinda citrifolia (noni) in high-fat diet-induced obese mice.
Nerurkar PV; Nishioka A; Eck PO; Johns LM; Volper E; Nerurkar VR
Br J Nutr; 2012 Jul; 108(2):218-228. PubMed ID: 22011624
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hepatic insulin-like growth factor-binding protein-1 gene expression by insulin: central role for mammalian target of rapamycin independent of forkhead box O proteins.
Mounier C; Dumas V; Posner BI
Endocrinology; 2006 May; 147(5):2383-91. PubMed ID: 16455781
[TBL] [Abstract][Full Text] [Related]
17. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c.
Hagiwara A; Cornu M; Cybulski N; Polak P; Betz C; Trapani F; Terracciano L; Heim MH; Rüegg MA; Hall MN
Cell Metab; 2012 May; 15(5):725-38. PubMed ID: 22521878
[TBL] [Abstract][Full Text] [Related]
18. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
[TBL] [Abstract][Full Text] [Related]
19. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
[TBL] [Abstract][Full Text] [Related]
20. Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.
Jiao P; Feng B; Xu H
PLoS One; 2012; 7(7):e41168. PubMed ID: 22848439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
